Prelude Therapeutics (PRLD)

Prelude Therapeutics (PRLD) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• PRLD last traded at $3.88, -5.37% on the day.
• Prelude Therapeutics: P/E -4.8, revenue $22.42M over the last four quarters.
• Over the past year PRLD returned 147.13%; year to date 33.79%.

Updated 2026-11-02 17:49 UTC